PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM)
CUSIP: 70387R403
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 6,367,621
- Total 13F shares
- 1,224,831
- Share change
- +13,287
- Total reported value
- $735,397
- Price per share
- $0.60
- Number of holders
- 29
- Value change
- +$3,569
- Number of buys
- 8
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 70387R403?
CUSIP 70387R403 identifies PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 70387R403:
Top shareholders of PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
— |
9.9%
|
1,226,316
|
$858,421 | $0 | 31 Dec 2024 | |
| FIRST MANHATTAN CO. LLC. |
13F
13D/G
|
Company |
4.3%
from 13D/G
|
714,100
|
$515,152 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
92,674
|
$66,869 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
81,494
|
$58,757 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
72,660
|
$52,417 | — | 31 Mar 2025 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
1%
|
65,047
|
$46,925 | — | 31 Mar 2025 | |
| James L. Cox |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| Joan B. Harvey |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.87%
|
55,531
|
$40,060 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.37%
|
23,427
|
$16,900 | — | 31 Mar 2025 | |
| Obermeyer Wealth Partners |
13F
|
Company |
0.34%
|
21,500
|
$15,510 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.33%
|
20,854
|
$15,044 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
11,706
|
$8,445 | — | 31 Mar 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.17%
|
11,119
|
$8,000 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.17%
|
10,686
|
$7,709 | — | 31 Mar 2025 | |
| XML Financial, LLC |
13F
|
Company |
0.16%
|
10,067
|
$7,262 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
4,792
|
$3,457 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
4,503
|
$3,248 | — | 31 Mar 2025 | |
| CWM, LLC |
13F
|
Company |
0.07%
|
4,672
|
$3,000 | — | 31 Mar 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.04%
|
2,241
|
$1,617 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
1,444
|
$1,042 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
4,364
mixed-class rows
|
$855 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
class O/S missing
|
149,408
|
$837 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
836
|
$503 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
41,721
|
$234 | — | 31 Mar 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
295
|
$223 | — | 31 Mar 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
246
|
$185 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
108
|
$78 | — | 31 Mar 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
95
|
$68 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
93
|
$67 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
74
|
$52 | — | 31 Mar 2025 | |
| Binnacle Investments Inc |
13F
|
Company |
0%
|
67
|
$48 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
19
|
$14 | — | 31 Mar 2025 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
5
|
$4 | — | 31 Mar 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2025 | |
| Brian J. DeGuzman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
50,000
|
— | — | 18 Feb 2022 |
Institutional Holders of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.